Cleared Traditional

K071760 - MODIFICATION TO: ECLIPSE TREATMENT PLANNING SYSTEM

K071760 is an FDA 510(k) clearance for MODIFICATION TO: ECLIPSE TREATMENT PLAN..., manufactured by Varian Medical Systems, Inc.. The device is a Class 2 Radiology device with product code MUJ cleared through the Traditional 510(k) pathway after a 133-day FDA review.

K071760 · Varian Medical Systems, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2007
Decision
133d
Days
Class 2
Risk

K071760 is an FDA 510(k) clearance for the MODIFICATION TO: ECLIPSE TREATMENT PLANNING SYSTEM. Classified as System, Planning, Radiation Therapy Treatment (product code MUJ), Class II - Special Controls.

Submitted by Varian Medical Systems, Inc. (Palo Alto, US). The FDA issued a Cleared decision on November 9, 2007 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Varian Medical Systems, Inc. devices

FDA 510(k) Submission Details - K071760

510(k) Number K071760 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 29, 2007
Decision Date November 09, 2007
Days to Decision 133 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
26d slower than avg
Panel avg: 107d · This submission: 133d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MUJ Device Classification - Class 2, Special Controls

Product Code MUJ System, Planning, Radiation Therapy Treatment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUJ System, Planning, Radiation Therapy Treatment

All 214
Devices cleared under the same product code (MUJ) and FDA review panel - the closest regulatory comparables to K071760.
OCENTRA MASTERPLAN 3.1 (OCENTRA BRACHY)
K081281 · Nucletron Corporation · May 2008
ONCENTRA GYN
K080929 · Nucletron Corporation · Apr 2008
ECLIPSE TREATMENT PLANNING SYSTEM
K073020 · Varian Medical Systems, Inc. · Dec 2007
MONACO RTP SYSTEM
K071938 · Computerized Medical Systems, Inc. · Oct 2007
MODIFICATION TO ECLIPSE TREATMENT PLANNING SYSTEM
K071873 · Varian Medical Systems, Inc. · Aug 2007
INTEGRA RADIONICS IMAGEFUSION 3
K063230 · Integra Radionics, Inc. · Dec 2006